Zumutor Biologics, an Immuno-Oncology company, has raised $4 million in Series A2 funding led by new investor Bharat Innovation Fund (BIF). The round also saw participation from its existing investor Accel Partners. With this round, the total funding raised by the startup stands at around $20 million. The company was founded in 2015 by Kavitha Iyer Rodrigues